Last10K.com

Nexien Biopharma, Inc. (NXEN) SEC Filing 8-K Material Event for the period ending Tuesday, March 31, 2020

Nexien Biopharma, Inc.

CIK: 1625288 Ticker: NXEN

View differences made from one to another to evaluate Nexien Biopharma, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Nexien Biopharma, Inc..

Continue

Assess how Nexien Biopharma, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Nexien Biopharma, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: NXEN
CIK: 1625288
Form Type: 8-K Corporate News
Accession Number: 0001493152-20-005890
Submitted to the SEC: Mon Apr 06 2020 3:04:45 PM EST
Accepted by the SEC: Mon Apr 06 2020
Period: Tuesday, March 31, 2020
Industry: Pharmaceutical Preparations
Events:
  1. Event for Officers

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/nxen/0001493152-20-005890.htm